Treatment
|
Concentration
|
Anti-inflammatory activities (% Inhibition)
|
---|
COX1
|
COX2
|
15-LOX
|
sPLA2
|
---|
Control
|
–
|
45.26 ± 2.31b
|
33.40 ± 1.02ab
|
51.46 ± 3.19b
|
55.95 ± 2.09b
|
Yeast extract (mg/L)
|
1
|
43.01 ± 1.05b
|
31.74 ± 3.76b
|
48.90 ± 2.42b
|
53.17 ± 1.87b
|
10
|
37.91 ± 4.01bc
|
27.98 ± 1.43bc
|
43.10 ± 1.13bc
|
46.87 ± 2.61c
|
50
|
44.76 ± 2.24b
|
33.03 ± 1.27ab
|
50.88 ± 0.88b
|
55.32 ± 3.13b
|
100
|
52.20 ± 1.31a
|
38.52 ± 0.79a
|
59.35 ± 1.13a
|
64.53 ± 2.25a
|
200
|
37.60 ± 3.56bc
|
27.75 ± 3.14bc
|
42.75 ± 3.02bc
|
46.48 ± 1.13c
|
Pectin (mg/L)
|
1
|
27.05 ± 0.72cd
|
19.96 ± 2.61
|
30.75 ± 2.65d
|
33.44 ± 2.25de
|
10
|
30.59 ± 1.38c
|
22.57 ± 2.44c
|
34.78 ± 3.63cd
|
37.82 ± 3.41d
|
50
|
26.27 ± 0.94cd
|
19.39 ± 1.83d
|
29.87 ± 1.22d
|
32.48 ± 2.72de
|
100
|
42.44 ± 1.61b
|
31.32 ± 1.68b
|
48.25 ± 1.63b
|
52.46 ± 1.37bc
|
250
|
40.46 ± 1.44bc
|
29.85 ± 0.95b
|
45.99 ± 2.24bc
|
50.01 ± 2.01bc
|
500
|
33.33 ± 1.75c
|
24.60 ± 1.28bc
|
37.90 ± 1.96c
|
41.21 ± 0.99cd
|
- Values represent means ± standard errors from triplicates; different letters indicate significant differences at p < 0.05